PRSS35 Antikörper (AA 30-340)
-
- Target Alle PRSS35 Antikörper anzeigen
- PRSS35 (Protease, serine, 35 (PRSS35))
-
Bindungsspezifität
- AA 30-340
-
Reaktivität
- Human, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser PRSS35 Antikörper ist unkonjugiert
-
Applikation
- ELISA, Western Blotting (WB)
- Verwendungszweck
- Anti-PRSS35 Antibody Picoband®
- Kreuzreaktivität (Details)
- No cross-reactivity with other proteins.
- Produktmerkmale
- Anti-PRSS35 Antibody Picoband® (ABIN7601219). Tested in ELISA, WB applications. This antibody reacts with Human, Rat. The brand Picoband indicates this is a premium antibody that guarantees superior quality, high affinity, and strong signals with minimal background in Western blot applications. Only our best-performing antibodies are designated as Picoband, ensuring unmatched performance.
- Aufreinigung
- Immunogen affinity purified.
- Immunogen
- E.coli-derived human PRSS35 recombinant protein (Position: H30-D340).
- Isotyp
- IgG
- Top Product
- Discover our top product PRSS35 Primärantikörper
-
-
- Applikationshinweise
-
Western blot, 0.25-0.5 μg/mL, Human, Rat
ELISA, 0.1-0.5 μg/mL, -
1. Miyakoshi, K. , Murphy, M. J. , Yeoman, R. R. , Mitra, S. , Dubay, C. J. , & Hennebold, J. D. . (2006). The identification of novel ovarian proteases through the use of genomic and bioinformatic methodologies. Biology of Reproduction, 75(6), 823-35. 2. Floyd, Brendan, J. , Wilkerson, Emily, M. , Veling, & Mike, T. , et al. Mitochondrial Protein Interaction Mapping Identifies Regulators of Respiratory Chain Function. 3. Clark, H. F. , Gurney, A. L. , Abaya, E. , Baker, K. , Baldwin, D. , & Brush, J. , et al. (2003). The secreted protein discovery initiative (spdi), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment. Genome Research, 13(10), 2265-2276. - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Adding 0.2 mL of distilled water will yield a concentration of 500 μg/mL.
- Konzentration
- 500 μg/mL
- Buffer
- Each vial contains 4 mg Trehalose, 0.9 mg NaCl, 0.2 mg Na2HPO4.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
-
At -20°C for one year from date of receipt. After reconstitution, at 4°C for one month.
It can also be aliquotted and stored frozen at -20°C for six months. Avoid repeated freezing and thawing.
-
- Target
- PRSS35 (Protease, serine, 35 (PRSS35))
- Andere Bezeichnung
- PRSS35 (PRSS35 Produkte)
- Hintergrund
-
Synonyms: Transmembrane protein 240,TMEM240,C1orf70,
Tissue Specificity: Detected in liver, skeletal muscle, kidney, pancreas, spleen, thyroid, testis, ovary, small intestine and colon.
Background: Proteolytic degradation of extracellular matrix components has been suggested to play an essential role for the occurrence of ovulation. The plasminogen activator and matrix metalloproteinase systems, which were previously believed to be crucial for ovulation, are not required in this process. PRSS35, which was upregulated by gonadotropins. PRSS23 was highly expressed in atretic follicles and it was expressed in the ovarian stroma and theca tissues just prior to ovulation. PRSS35 was expressed in the theca layers of developing follicles. It was also highly induced in granulosa cells of preovulatory follicles. PRSS35 was also expressed in the forming and regressing CL. PRSS35 may be involved in ovulation and CL formation and regression, and that PRSS23 may play a role in follicular atresia.
- Molekulargewicht
- 53 kDa
- Gen-ID
- 167681
- UniProt
- Q8N3Z0
-